Literature DB >> 23727134

The dynamics of polycomb group proteins in early embryonic nervous system in mouse and human.

Lu Qi1, Jing-Li Cao, Yi Hu, Ji-Gao Yang, Yuan Ji, Jing Huang, Yi Zhang, Da-Guang Sun, Hong-Fei Xia, Xu Ma.   

Abstract

Polycomb group (PcG) proteins are transcription regulatory proteins that control the expression of a variety of genes and the antero-posterior neural patterning from early embryogenesis. Although expression of PcG genes in the nervous system has been noticed, but the expression pattern of PcG proteins in early embryonic nervous system is still unclear. In this study, we analyzed the expression pattern of PRC1 complex members (BMI-1 and RING1B) and PRC2 complex members (EED, SUZ12 and EZH2) in early embryonic nervous system in mouse and human by Western blot and Immunohistochemistry. The results of Western blot showed that EED protein was significantly up-regulated with the increase of the day of pregnancy during the early embryogenesis in mouse. BMI-1 protein level was significantly increased from the day 10 of pregnancy, when compared with the day 9 of pregnancy. But the SUZ12, EZH2 and RING1B protein level did not change significantly. From the results of Immunohistochemistry, we found that the four PcG proteins were all expressed in the fetal brain and fetal spinal cord in mouse. In human, the expression of EED, SUZ12, and EZH2 was not significantly different in cerebral cortex and sacral spinal cord, but BMI-1 and RING1B expression was enhanced with the development of embryos in early pregnancy. Collectively, our findings showed that PRC1 and PRC2 were spatiotemporally expressed in brain and spinal cord of early embryos.
Copyright © 2013 ISDN. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Human; Mouse; Neurogenesis; PRC1; PRC2

Mesh:

Substances:

Year:  2013        PMID: 23727134     DOI: 10.1016/j.ijdevneu.2013.05.005

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  3 in total

1.  De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma.

Authors:  Jack M Shireman; Fatemeh Atashi; Gina Lee; Eunus S Ali; Miranda R Saathoff; Cheol H Park; Sol Savchuk; Shivani Baisiwala; Jason Miska; Maciej S Lesniak; C David James; Roger Stupp; Priya Kumthekar; Craig M Horbinski; Issam Ben-Sahra; Atique U Ahmed
Journal:  Brain       Date:  2021-05-07       Impact factor: 13.501

2.  Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology.

Authors:  Kimberley J Billingsley; Maurizio Manca; Olympia Gianfrancesco; David A Collier; Helen Sharp; Vivien J Bubb; John P Quinn
Journal:  Schizophr Res       Date:  2018-02-28       Impact factor: 4.939

3.  The Dynamic Partnership of Polycomb and Trithorax in Brain Development and Diseases.

Authors:  Janise N Kuehner; Bing Yao
Journal:  Epigenomes       Date:  2019-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.